Enhance Your Professional Skills With MTU's Online Certificate in Quality Engineering. Quality engineering involves the use of methodologies, processes, and tools to improve product development.

The school’s management-oriented certificate program focuses on quality as a priority. Developed in cooperation with industry, the courses can help students develop a total quality management ...

These therapies aim to safeguard the patient's health and quality of life as much as possible. Daiichi Sankyo is solidifying its position as a leader in oncology by making substantial investments ...

Daiichi Sankyo’s antibody-drug conjugate (ADC) platform has already delivered one drug to the market with blockbuster sales forecasts, with a second due to be filed shortly. Now, a third is ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

(RTTNews) - Alteogen Inc. said that it has entered into an exclusive license agreement with Daiichi Sankyo (DSKYF.PK). As per the terms of the deal, Daiichi Sankyo will acquire world-wide rights ...

Commissions do not affect our editors’ opinions or evaluations. Though many people use the terms interchangeably, certificates and certifications are not the same. Understanding the differences ...

Japan's Daiichi Sankyo applies for approval of mRNA COVID vaccine Approval would give Japan a home-grown mRNA vaccine of the type that has made up the bulk of its COVID inoculations so far.

Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous version of its AstraZeneca-partnered cancer drug Enhertu. Alteogen will ...

Propel your career forward with an accredited graduate certificate. Quality engineering is crucial to business success, safeguarding consumer interest and needs, and ensuring that uniformity, ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...